- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Hyperplasia in Canada
Total 794 results
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
IpsenCompleted
-
Laval UniversityUnknown
-
NCIC Clinical Trials GroupCompletedProstate CancerUnited States, Canada
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...Completed
-
Astellas Pharma Europe B.V.CompletedAdvanced Prostate CarcinomaRussian Federation
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
ATGen Canada IncTerminatedProstatic Neoplasm | Immunity, InnateCanada
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerCanada
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
University Health Network, TorontoActive, not recruiting
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Southwest Oncology GroupCompleted
-
University Health Network, TorontoRecruitingBariatric Surgery Candidate | Endometrial Cancer | Atypical HyperplasiaCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
British Columbia Cancer AgencyRecruitingProstatic Cancer | Prostatic NeoplasmCanada
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
NCIC Clinical Trials GroupOncothyreon Canada Inc.Completed
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Netherlands, Hungary, Czech Republic, Germany, Mexico, Romania, Russian Federation, Ukraine, Canada, Puerto Rico, United Kingdom
-
MedImmune LLCCompletedProstate CancerUnited States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
-
ESSA PharmaceuticalsRecruitingProstate CancerUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Institute... and other collaboratorsTerminated
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerCanada, United States
-
Eisai Inc.CompletedProstate CancerFrance, United States, Romania, Canada, Peru, Brazil, Russian Federation, Chile, Croatia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Canada
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Ottawa Hospital Research InstituteTerminated
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Active Biotech ABCompleted
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Puerto Rico
-
Sunnybrook Health Sciences CentreWithdrawn
-
Sunnybrook Health Sciences CentreCompleted
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
GAAD Medical Research Institute Inc.Unknown
-
NovaceaAventis PharmaceuticalsUnknownProstate CancerCanada, United States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
AbbottCompletedAdenocarcinoma | Prostate CancerCanada, United States, France, Netherlands, United Kingdom